| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/14/1990 | CA2005247A1 Process and composition for increasing brain dopamine release |
| 06/14/1990 | CA2005205A1 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition |
| 06/13/1990 | EP0372998A2 Use of benzopyran derivatives in the treatment of epilepsy |
| 06/13/1990 | EP0372070A1 Method for making solvent dilution microcarriers. |
| 06/13/1990 | EP0372062A1 Inhibition of lipogenesis |
| 06/12/1990 | CA2004979A1 Production and use of porphyrins |
| 06/12/1990 | CA1270198A1 Encapsulation of antineoplastic agents in liposomes |
| 06/12/1990 | CA1270197A1 Dehydrated liposomes |
| 06/08/1990 | CA2004777A1 Treatment |
| 06/07/1990 | DE3812605A1 Immunregulative stoffe und stoffgemische zur aktiven beeinflussung des krankheitsverlaufes Immune regulative substances and substance mixtures of active influencing the course of disease |
| 06/06/1990 | EP0371598A1 Antidotes |
| 06/06/1990 | EP0371508A1 Phenoxy and phenylthio, amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections |
| 06/06/1990 | EP0371466A1 Fast buccal tablet |
| 06/06/1990 | EP0371085A1 Dextromethorphan potentiator for anticonvulsant composition and method |
| 06/05/1990 | US4931468 Treating malignant tumors with g-linolenic or dihomo-g-lino-lenic acid or derivatives; combined with zinc, antibiotics |
| 06/05/1990 | US4931460 Post-ischemic myocardial dysfunction using thromboxane A2 antagonists |
| 05/31/1990 | WO1990005755A1 Collagen-polymer conjugates |
| 05/31/1990 | WO1990005542A1 Medicament for treatment of pathological vascular permeability and plasma loss to tissue |
| 05/31/1990 | WO1990005541A1 Immunotherapy involving cd28 stimulation |
| 05/31/1990 | WO1990005539A1 Antibodies specific for elam-1 and the use thereof |
| 05/31/1990 | WO1990005536A1 Products and process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans |
| 05/31/1990 | WO1990005531A1 Method for treating vascular diseases |
| 05/31/1990 | CA2004033A1 Fast buccal tablet |
| 05/28/1990 | CA2003940A1 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
| 05/23/1990 | EP0369880A1 Pharmaceutical compounds active on presbyopia, and process for their preparation |
| 05/23/1990 | EP0368933A1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes |
| 05/23/1990 | EP0368920A1 Lectines fixing beta-d-galactoside. |
| 05/21/1990 | CA2003385A1 A method for enhancing the lowering of plasma cholesterol levels |
| 05/21/1990 | CA2003382A1 Method for treating vascular diseases |
| 05/17/1990 | WO1990004965A1 Dosage form having reduced abuse potential |
| 05/17/1990 | WO1990001927A3 Use of paf antagonists for treating autoimmune diseases |
| 05/16/1990 | EP0368367A1 Purification, production and use of tumor necrosis factors |
| 05/16/1990 | EP0368232A1 Thrombolytic therapy |
| 05/16/1990 | CN1042072A Use of asymmetric membranes in delivery devices |
| 05/15/1990 | US4925873 Prostaglandin derivatives or substituted phenylacetic acids |
| 05/15/1990 | US4925869 Reactivating enzyme acetylcholinesterase inhibited by lethal dose of soman |
| 05/15/1990 | US4925837 Synergistic combination of alpha-blocker and calcium antagonist; hypotensive agents |
| 05/15/1990 | US4925672 Products containing a calcium antagonist and a lipid-lowering agent |
| 05/15/1990 | US4925669 Zeoliate or pillared caly substrate |
| 05/15/1990 | US4925648 Two specific antibodies(or fragments) bound to imaging agents |
| 05/14/1990 | CA2002860A1 Antibodies specific for elam-1 and the use thereof |
| 05/09/1990 | EP0367724A1 Improvements in or relating to organic compounds |
| 05/09/1990 | EP0367484A1 Carboxylic acid derivates |
| 05/08/1990 | US4923854 Solubilization of hydrophobic materials using lysophospholipid |
| 05/03/1990 | WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment |
| 05/03/1990 | WO1990004390A1 Composition for inhibiting transmission of aids |
| 05/03/1990 | WO1990004388A1 In vivo neurotrophic cytoprotective alcohols |
| 05/03/1990 | WO1990004387A2 Compositions for treating tobacco withdrawal symptoms |
| 05/03/1990 | WO1990004386A1 Orally pharmaceutical preparations with colon selective delivery |
| 05/02/1990 | EP0366621A1 Orally pharmaceutical preparations with colon selective delivery |
| 05/02/1990 | EP0366033A2 Method of improving post-ischemic myocardial dysfunction using an ace inhibitor alone or in combination with a thrombolytic agent and combination |
| 05/02/1990 | EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment |
| 05/02/1990 | EP0365656A1 Prophylactic and therapeutic methods for treating edema with phallotoxins |
| 05/01/1990 | US4921874 Medicinal bath oils |
| 04/24/1990 | US4920149 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| 04/24/1990 | US4920101 For enhancing penetration of physiologically active agents through skin or other membranes |
| 04/24/1990 | US4919915 Method for detecting the ability to prevent red-to-green congophilic birefringence |
| 04/24/1990 | CA2000469A1 Method of improving post-ischemic myocardial dysfunction using and ace inhibitor alone or in combination with a thrombolytic agent and combination |
| 04/24/1990 | CA1268118A1 Method for preparing infection-resistant materials |
| 04/19/1990 | WO1990004017A1 Animal model for human disease |
| 04/19/1990 | WO1990003801A1 Vasopermeability-enhancing conjugates |
| 04/19/1990 | WO1990003798A2 Targetting agents |
| 04/19/1990 | WO1990003776A1 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 04/18/1990 | EP0364266A2 NSAID and/or EGF for enhancing the healing of corneal endothelial wounds |
| 04/18/1990 | EP0363712A2 Hybrid monoclonal antibodies, their production and use |
| 04/18/1990 | EP0363671A2 Use of ACE inhibitors against the formation of neo-intima after vascular infliction |
| 04/18/1990 | EP0363355A1 Medicament containing local anesthetics and nucleosides and its use for treating muscular injuries |
| 04/18/1990 | CA2000940A1 In vivo neurotrophic cytoprotective alcohols |
| 04/17/1990 | US4918165 Anticollagen antibody and cytotoxin conjugate |
| 04/14/1990 | CA2000697A1 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 04/12/1990 | CA2000537A1 Method for enhancing healing of corneal endothelial wounds |
| 04/11/1990 | EP0362645A2 Use of pteridines in the prevention of the primary and secondary resistance during chemotherapy, and medicaments containing these compounds |
| 04/11/1990 | EP0362297A1 Hepatic blocking agents |
| 04/10/1990 | US4916070 Fibrin-specific antibodies and method of screening for the antibodies |
| 04/10/1990 | CA1267605A1 Pharmaceutical composition containing phenindamine |
| 04/05/1990 | WO1990003401A1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
| 04/05/1990 | WO1990003184A1 Matrix with immunomodulating activity |
| 04/05/1990 | WO1990003167A1 Compositions and methods for administering therapeutically active compounds |
| 04/04/1990 | EP0361077A2 Use of PAF antagonists in the treatment of autoimmune disorders |
| 03/28/1990 | EP0360077A2 Use of serotonin antagonists in the treatment of apoplexia cerebri |
| 03/28/1990 | EP0359981A1 Pharmaceutical combinations and their use as antineoplastic medicines |
| 03/27/1990 | US4912096 Such as 1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy 1-oxohexyl)proline, fosinopril or zofenopril |
| 03/27/1990 | CA1267085A1 Stimulation of tear secretion |
| 03/22/1990 | WO1990002762A1 Macrophage-derived inflammatory mediator (mip-2) |
| 03/22/1990 | WO1990002561A2 Use of fibrinolytica for the combined treatment of tumors |
| 03/22/1990 | WO1990002551A2 Prophylaxis and treatment of nervous system diseases with melanin |
| 03/22/1990 | WO1990002550A1 Treatment of damaged bone marrow and dosage units therefor |
| 03/22/1990 | WO1990002545A1 Composition for the treatment of erectile dysfunction |
| 03/22/1990 | DE3930928A1 Cyclosporin compsns. in microemulsion or pre-concentrate form |
| 03/21/1990 | EP0359347A2 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 03/21/1990 | EP0359282A2 Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic compositions containing same |
| 03/14/1990 | EP0357793A1 Suspended-release preparation prepared by using alginates |
| 03/14/1990 | EP0357725A1 Pharmaceutical composition for treatment of lung obstructions. |
| 03/13/1990 | US4908387 Use of beta2 antagonists in the treatment of inflammatory diseases, in particular, rheumatoid arthritis |
| 03/13/1990 | US4908380 Substituted 1,3-dioxane ether derivative; thromboxane A2 inhibitor |
| 03/08/1990 | WO1990001951A1 Molecular conjugates containing cell membrane-blending agents |
| 03/08/1990 | WO1990001935A1 Use of an agent active against retrovirus and products so produced |
| 03/08/1990 | WO1990001927A2 Use of paf antagonists for treating autoimmune diseases |
| 03/07/1990 | EP0357581A1 Composition for the treatment of erectile dysfunction |
| 03/07/1990 | EP0357369A2 The use of asymetric membranes in delivery devices |